{
    "organizations": [],
    "uuid": "91e8474cbe21a8e9a3c05c6c8f5988cb4e2e49e3",
    "author": "",
    "url": "https://www.reuters.com/article/brief-egalet-partners-with-orapharma-to/brief-egalet-partners-with-orapharma-to-co-promote-sprix-nasal-spray-idUSFWN1OX0RP",
    "ord_in_thread": 0,
    "title": "BRIEF-Egalet Partners With Orapharma To Co-Promote Sprix Nasal Spray",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 12 AM / Updated 3 minutes ago BRIEF-Egalet Partners With Orapharma To Co-Promote Sprix Nasal Spray Reuters Staff \nJan 3 (Reuters) - Egalet Corp: \n* EGALET PARTNERS WITH ORAPHARMA TO CO-PROMOTE SPRIX® NASAL SPRAY \n* EGALET CORP - FINANCIAL TERMS OF AGREEMENT WILL NOT BE DISCLOSED \n* EGALET CORP - ‍ORAPHARMA WILL BEGIN PROMOTING SPRIX IN Q1 AS PART OF A TWO-YEAR AGREEMENT​ \n* EGALET CORP - HAS TERMINATED ITS AGREEMENT WITH SEPTODONT Source text for Eikon: Further company coverage:",
    "published": "2018-01-03T13:11:00.000+02:00",
    "crawled": "2018-01-03T13:25:36.018+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "updated",
        "minute",
        "ago",
        "partner",
        "orapharma",
        "sprix",
        "nasal",
        "spray",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "egalet",
        "corp",
        "egalet",
        "partner",
        "orapharma",
        "nasal",
        "spray",
        "egalet",
        "corp",
        "financial",
        "term",
        "agreement",
        "disclosed",
        "egalet",
        "corp",
        "begin",
        "promoting",
        "sprix",
        "q1",
        "part",
        "egalet",
        "corp",
        "terminated",
        "agreement",
        "septodont",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}